Prostate cancer has become 1 of the most commonly diagnosed cancers in the
United States and 1 of the leading causes of cancer death in North America
and Western Europe. Survey studies of prostate tissues obtained at autopsy
indicate that the development of life-threatening prostate cancer in the US
likely occurs over decades. Insights from epidemiologic studies implicate
environmental factors, principally dietary components, as major risk factor
s for prostate cancer development. An accumulating body of basic research d
ata suggests that normal and neoplastic prostate cells may be subjected to
a relentless barrage of genome-damaging stresses, and that dietary componen
ts and male sex steroids might modulate the level of genome threatening ins
ults. Finally, over the past 5 years, analyses of somatic genome alteration
s in prostatic carcinoma cells have revealed that somatic inactivation of G
STP1, encoding the carcinogen-detoxification enzyme glutathione S-transfera
se pi, may serve as an initiating genome lesion for prostatic carcinogenesi
s. These diverse observations can be integrated into a transcendent mechani
stic hypothesis for the pathogenesis of prostate cancer: normal prostate ce
lls acquiring somatic GSTP1 defects may suffer chronic genome damage, influ
enced by dietary practices, that promote neoplastic transformation, while p
rostatic carcinoma cells, which characteristically contain defective GSTP1
alleles, remain susceptible to further genome-damaging stresses that promot
e malignant cancer progression. This hypothesized critical role for GSTP1 i
nactivation in the earliest steps of prostatic carcinogenesis provides seve
ral attractive opportunities for prostate cancer prevention strategies, inc
luding (1) restoration of GSTP1 function, (2) compensation for inadequate G
STP1 activity (via use of therapeutic inducers of other glutathione S-trans
ferases (GST), and (3) abrogation or attenuation of genome-damaging stresse
s. (C) 2001, Elsevier Science Inc.